ACADIA Pharmaceuticals
ACAD
#3225
Rank
HK$35.22 B
Marketcap
HK$208.20
Share price
-2.48%
Change (1 day)
42.65%
Change (1 year)

ACADIA Pharmaceuticals (ACAD) - Total debt

Total debt on the balance sheet as of September 2025 : HK$0.42 Billion

According to ACADIA Pharmaceuticals's latest financial reports the company's total debt is HK$0.42 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

ACADIA Pharmaceuticals - Total debt on balance sheet (from 2003 to 2025)

Total debt by year

Year Total debt Change
2024-12-31HK$0.40 B-9.65%
2023-12-31HK$0.44 B-7.77%
2022-12-31HK$0.48 B-3.58%
2021-12-31HK$0.50 B30.8%
2020-12-31HK$0.38 B403.51%
2019-12-31HK$76.28 M
2018-12-31N/A
2011-12-31HK$0.24 M-70.97%
2010-12-31HK$0.85 M-76.15%
2009-12-31HK$3.58 M-62.08%
2008-12-31HK$9.46 M-43.11%
2007-12-31HK$16.63 M-9.92%
2006-12-31HK$18.47 M33.69%
2005-12-31HK$13.81 M-29.73%
2004-12-31HK$19.66 M-47.88%
2003-12-31HK$37.72 M-24.82%
2002-12-31HK$50.17 M386.38%
2001-12-31HK$10.31 M-77.15%
2000-12-31HK$45.15 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Vanda Pharmaceuticals
VNDA
HK$84.91 M-80.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
HK$473.40 B 110,918.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
HK$330.70 B 77,454.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
HK$356.28 B 83,453.80%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
HK$397.10 B 93,025.22%๐Ÿ‡บ๐Ÿ‡ธ USA
Adamas Pharmaceuticals
ADMS
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA